Skip to main content
Top
Published in: Sleep and Breathing 4/2022

26-11-2021 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Original Article

Multiple-access versus telemedicine home-based sleep apnea testing for obstructive sleep apnea (OSA) diagnosis: a cost-minimization study

Authors: Marcello Di Pumpo, Mario Cesare Nurchis, Antonio Moffa, Lucrezia Giorgi, Lorenzo Sabatino, Peter Baptista, Lorenzo Sommella, Manuele Casale, Gianfranco Damiani

Published in: Sleep and Breathing | Issue 4/2022

Login to get access

Abstract

Purpose

The aim of the present study was to compare two clinical pathways: the multiple-access outpatient pathway versus the telemedicine pathway.

Methods

The multiple-access outpatient pathway and the telemedicine pathway were both performed with WatchPAT and implemented in a real-life healthcare scenario, adopting a cost-minimization approach. A cost-minimization analysis was undertaken to assess the economic impact of the two alternatives. The cost analyses were performed in euros for the year 2021 adopting the patient, the hospital, and the societal perspectives. Given the chosen perspectives, direct medical costs, direct nonmedical costs, and indirect costs were considered. In addition, a univariate sensitivity analysis was conducted.

Results

From a hospital perspective, the telemedicine approach was estimated to cost €49 more than the multiple-access alternative. Considering the patient perspective, the telemedicine approach was estimated to cost €167 less than the multiple-access pathway. Considering the societal perspective, the telemedicine approach is estimated to cost €119 less than the multiple-access pathway.

Conclusion

The adoption of telemedicine home sleep apnea testing could improve the efficiency of the healthcare processes if considering the direct and indirect costs incurred by patients and not only by healthcare providers.
Literature
19.
go back to reference Azienda Sanitaria Locale Roma 2 PARM 2020. Piano Annuale di Risk Management ASL Roma 2. Roma Azienda Sanitaria Locale Roma 2 PARM 2020. Piano Annuale di Risk Management ASL Roma 2. Roma
20.
go back to reference Istituto Nazionale della Previdenza Sociale (2021) Orario di Lavoro Istituto Nazionale della Previdenza Sociale (2021) Orario di Lavoro
21.
go back to reference Istituto Nazionale di Statistica (2019) Differenziali Retributivi in Italia. Roma Istituto Nazionale di Statistica (2019) Differenziali Retributivi in Italia. Roma
25.
go back to reference Regione Lazio (2013) Approvazione Nomenclatore Tariffario Regionale per Prestazioni di Assistenza Specialistica Ambulatoriale.D.M. 18.10.2012 Regione Lazio (2013) Approvazione Nomenclatore Tariffario Regionale per Prestazioni di Assistenza Specialistica Ambulatoriale.D.M. 18.10.2012
31.
go back to reference Gold M, Siegel J, Russel L, et al (1997) Cost-effectiveness in health and medicine. John Wiley and Sons Ltd Gold M, Siegel J, Russel L, et al (1997) Cost-effectiveness in health and medicine. John Wiley and Sons Ltd
33.
go back to reference Andronis L, Barton P, Bryan S (2009) Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technol Assess (Rockv) 13. https://doi.org/10.3310/hta13290 Andronis L, Barton P, Bryan S (2009) Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technol Assess (Rockv) 13. https://​doi.​org/​10.​3310/​hta13290
35.
go back to reference The Health Foundation (2020) Non-COVID-19 NHS care during the pandemic. Activity trends for key NHS services in England The Health Foundation (2020) Non-COVID-19 NHS care during the pandemic. Activity trends for key NHS services in England
39.
go back to reference Redline S, Sanders MH, Lind BK et al (1998) Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep 21:759–767 Redline S, Sanders MH, Lind BK et al (1998) Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep 21:759–767
42.
go back to reference Stendardo M, Schito M, Casillo V, et al (2017) Obstructive sleep apnea syndrome and work ability. In: Occupational and Environmental Health. European Respiratory Society, p PA1239 Stendardo M, Schito M, Casillo V, et al (2017) Obstructive sleep apnea syndrome and work ability. In: Occupational and Environmental Health. European Respiratory Society, p PA1239
45.
go back to reference European Network For Health Technology Assessment (2016) HTA Core Model Version 3.0 European Network For Health Technology Assessment (2016) HTA Core Model Version 3.0
Metadata
Title
Multiple-access versus telemedicine home-based sleep apnea testing for obstructive sleep apnea (OSA) diagnosis: a cost-minimization study
Authors
Marcello Di Pumpo
Mario Cesare Nurchis
Antonio Moffa
Lucrezia Giorgi
Lorenzo Sabatino
Peter Baptista
Lorenzo Sommella
Manuele Casale
Gianfranco Damiani
Publication date
26-11-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 4/2022
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-021-02527-5

Other articles of this Issue 4/2022

Sleep and Breathing 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine